| Product NDC: | 49884-658 |
| Proprietary Name: | Candesartan cilexetil |
| Non Proprietary Name: | Candesartan cilexetil |
| Active Ingredient(s): | 4 mg/1 & nbsp; Candesartan cilexetil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-658 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020838 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20130521 |
| Package NDC: | 49884-658-09 |
| Package Description: | 90 TABLET in 1 BOTTLE (49884-658-09) |
| NDC Code | 49884-658-09 |
| Proprietary Name | Candesartan cilexetil |
| Package Description | 90 TABLET in 1 BOTTLE (49884-658-09) |
| Product NDC | 49884-658 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Candesartan cilexetil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130521 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | CANDESARTAN CILEXETIL |
| Strength Number | 4 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |